GO TO
CORPORATE MEMBERS
Board of Directors
TBI is governed by a Board of Directors that represent Ontario’s pharmaceutical and biotechnology industry. These elected directors provide guidance and set policy for TBI, facilitating The Biotechnology Intiative’s strong voice in advocacy and economic development in Ontario.
TBI Board of Directors, effective May 2007
| Grant Tipler | RBC Royal Bank |
| Karen Atkinson | Ernst & Young LLP |
| Matt Buist | City of Toronto, Office of Economic Dev. |
| Geoff Collett | Astrazeneca Canada Inc. |
| Jeffrey Graham | Borden Ladner Gervais LLP |
| Greg Hines | ArcticDx Inc. |
| Darlene Homonko | Golden Horseshoe Venture Forum |
| John Kelly | MaRS Landing |
| Jason Locklin | Sanofi Pasteur Limited |
| Tim McTiernan | The Innovations Group University of Toronto |
| Lorne Meikle | AFFERENCE Therapeutics |
| Anita Nador | McCarthy Tetrault |
| Allan O'Dette | GlaxoSmithKline Canada |
| Dale Patterson | Canadian Medical Discoveries Fund |
| Stan Shapson | York University |
| Adi Treasurywala | ArrowCan Partners |
